Ladarixin, a dual CXCR1/2 inhibitor, attenuates experimental melanomas harboring different molecular defects by affecting malignant cells and tumor microenvironment
Ladarixin 是一种双重 CXCR1/2 抑制剂，它通过影响恶性细胞和肿瘤微环境，减弱具有不同分子缺陷的实验性黑色素瘤的生长。
期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.14803
Kemp, Daria Marley; Pidich, Alyson; Larijani, Mary; Jonas, Rebecca; Lash, Elizabeth; Sato, Takami; Terai, Mizue; De Pizzol, Maria; Allegretti, Marcello; Igoucheva, Olga; Alexeev, Vitali
